Use access key #2 to skip to page content.
$47.40 2.04 (4.50%)
12/3/2008 4:06 PM

Novartis AG (ADR) (NVS)

CAPS Rating:
*****

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.

View Ticker Page (NVS)

Results 31 - 40 of 150 :   12345Next »

Recs

1

Avatar RyWoods (68.17) Submitted: 4/19/08 10:14 AM : Outperform Start Price: $49.61 NVS Score: 32.23

This looks like one of those stocks that the market has completely missed. Novartis is one of the best positioned companies in the pharmaceutical industry. They have great diversification, limiting the pitfalls pharmaceutical companies often face. ...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar zirotti (82.71) Submitted: 1/23/07 1:32 AM : Outperform Start Price: $55.35 NVS Score: 24.12

NVS is an industry leader. Extremely strong drug portfolio, great pipeline and successful generics business hedges their risk of patent expiration. Healthy balance sheet, good returns on capital.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar mitleg (< 20) Submitted: 7/15/08 12:17 PM : Outperform Start Price: $56.52 NVS Score: 12.36

Given the market volatility and all of the many downside risks to growth such as continued high oil prices and the weakness in the financial sector this is a good safe pick. The p/e is reasonable. I don't expect a great deal of upward movement gi...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar eremmell (< 20) Submitted: 4/03/08 11:49 PM : Outperform Start Price: $51.96 NVS Score: 27.69

It seems somewhat undervalued, plus the U.S. economy is hurting and investors are looking to invest outside the U.S.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar martinc6 (< 20) Submitted: 12/11/06 4:55 PM : Outperform Start Price: $55.51 NVS Score: 23.62

A press release put out today states that their leukemia drug has outperformed any other in recent testing. I'd buy it.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar RDiddy (< 20) Submitted: 11/06/06 4:47 PM : Outperform Start Price: $58.34 NVS Score: 17.95

NVS is one of the best positioned companies in the pharma space.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar tldupuy (86.25) Submitted: 8/26/06 12:28 AM : Outperform Start Price: $54.15 NVS Score: 20.07

Diversified product line. Strong generic presence. Stable dividend.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar JanessaB (26.31) Submitted: 10/18/06 12:12 PM : Outperform Start Price: $55.20 NVS Score: 22.11

Generics are going to be bigger and bigger, as more insurance companies raise drug copays and move higher-cost drugs to the higher co-pay tiers.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar TMFHelical (99.20) Submitted: 10/12/06 10:17 AM : Outperform Start Price: $54.69 NVS Score: 22.38

Good solid big pharma. Very well positioned to advantage biogenerics when the registration process becomes clearer.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar TMFKC (98.65) Submitted: 10/10/06 3:47 PM : Outperform Start Price: $54.94 NVS Score: 21.63

Novartis has a great range of drugs. I also like a company that will cut the cost of anti-malarial medicine to allow low-income countries greater access to the drug.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links